Is SCHD a Good ETF to Buy?
With around $65.7 billion in net assets, Schwab’s US Dividend…
Sell
34
NNGRY Quote, Financials, Valuation and Earnings
Last price:
$22.08
Seasonality move
:
-1.19%
Day range:
$22.03 - $22.35
52-week range:
$19.58 - $25.49
Dividend yield:
8.25%
P/E ratio:
9.55x
P/S ratio:
0.99x
P/B ratio:
0.52x
Volume:
37.3K
Avg. volume:
40.3K
1-year change:
9.13%
Market cap:
$11.8B
Revenue:
$11.9B
EPS (TTM):
$2.28
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $22.5B | $20.6B | $22.5B | -$687.6M | $11.9B | |
| Revenue Growth (YoY) | -3.52% | -8.56% | 9.38% | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $293.3M | $261.5M | $327.7M | -- | -- | |
| Other Inc / (Exp) | -$10.1M | -$495.6M | $795.1M | $735.1M | -$54.1M | |
| Operating Expenses | $17.8B | $1.3B | $1.2B | $2.4B | $2.9B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $581M | $583.6M | $616.4M | $621.2M | $1.1B | |
| EBT. Incl. Unusual Items | $2.7B | $2.5B | $4.5B | $683.4M | $1.7B | |
| Earnings of Discontinued Ops. | -- | $131.3M | $159.7M | $1.1B | -- | |
| Income Tax Expense | $497.1M | $439.7M | $791.5M | $113.9M | $376.7M | |
| Net Income to Company | $2.7B | $2.7B | $4.7B | $1.8B | $1.7B | |
| Minority Interest in Earnings | -$25.7M | -$25.1M | -$23.7M | $5.3M | -$13M | |
| Net Income to Common Excl Extra Items | $2.2B | $2.2B | $3.9B | $1.7B | $1.3B | |
| Basic EPS (Cont. Ops) | $3.22 | $3.36 | $6.16 | $2.81 | $2.19 | |
| Diluted EPS (Cont. Ops) | $3.22 | $3.35 | $6.16 | $2.81 | $2.19 | |
| Weighted Average Basic Share | $661M | $628.2M | $617.8M | $591M | $554.6M | |
| Weighted Average Diluted Share | $662M | $629.2M | $618.6M | $591.4M | $555M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $3.3B | $3.1B | $5.2B | $683.4M | $1.7B | |
| Revenue (Reported) | $22.5B | $20.6B | $22.5B | -$687.6M | $11.9B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $3.3B | $3.1B | $5.2B | $683.4M | $1.7B | |
| Period Ending | 2015-12-31 | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.9B | $2.5B | $5.4B | $5.3B | $4.5B | |
| Revenue Growth (YoY) | -54.81% | -10.67% | 110.23% | -1% | -14.33% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $32.8M | -$127.3M | -$43.6M | -$49.1M | -$35.4M | |
| Operating Expenses | $1.7B | $1.7B | $3.7B | $3B | $3.4B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $377.5M | $170.5M | $876.1M | -$438.1M | $374.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$18.6M | $10.8M | $37.7M | $162M | $5.5M | |
| Net Income to Company | -- | $162.7M | $765.8M | -$416.6M | $394.2M | |
| Minority Interest in Earnings | -$2.2M | -- | -$14.1M | -$8M | -$4.4M | |
| Net Income to Common Excl Extra Items | $393.9M | $159.7M | $824.3M | -$608.1M | $364.3M | |
| Basic EPS (Cont. Ops) | $0.58 | $0.23 | $1.21 | -$0.94 | $0.54 | |
| Diluted EPS (Cont. Ops) | $0.57 | $0.23 | $1.20 | -$0.94 | $0.54 | |
| Weighted Average Basic Share | $664.8M | $650.6M | $671.2M | $671.6M | $649M | |
| Weighted Average Diluted Share | $667.2M | $652.2M | $673.2M | $672.8M | $650M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $538.3M | $257.8M | $891.4M | -$304.6M | $523.8M | |
| Revenue (Reported) | $2.9B | $2.5B | $5.4B | $5.3B | $4.5B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $538.3M | $257.8M | $891.4M | -$304.6M | $523.8M | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $21.6B | $7.9B | $7.8B | $12.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$50.7M | -$57.7M | $1.4B | -$149.4M | $401.6M | |
| Operating Expenses | -- | $815.3M | $1.6B | $2.5B | $2.8B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $297.4M | $595.9M | $601.3M | $795.8M | $1.3B | |
| EBT. Incl. Unusual Items | -- | $3.6B | $3.3B | $706.9M | $1.7B | |
| Earnings of Discontinued Ops. | -- | $82M | $1.2B | -- | -- | |
| Income Tax Expense | -- | $563.5M | $519.6M | $161.6M | $374.7M | |
| Net Income to Company | -- | -- | $4.5B | $707.9M | -- | |
| Minority Interest in Earnings | -$11M | -$27.6M | $4.6M | -$15.7M | -$17.2M | |
| Net Income to Common Excl Extra Items | -- | $3.3B | $4B | $529.6M | $1.3B | |
| Basic EPS (Cont. Ops) | -- | $5.14 | $6.41 | $0.94 | $2.28 | |
| Diluted EPS (Cont. Ops) | -- | $5.14 | $6.40 | $0.93 | $2.28 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | $4.2B | -- | -- | -- | |
| Revenue (Reported) | -- | $21.6B | $7.9B | $7.8B | $12.3B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | $4.2B | -- | -- | -- | |
| Period Ending | 2021-01-08 | 2022-01-08 | 2023-01-08 | 2024-01-08 | ||
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $7.2B | $15.2B | $7.8B | $7.2B | $9.1B | |
| Short Term Investments | $131.8B | $145.4B | $169.8B | $123.4B | $121.7B | |
| Accounts Receivable, Net | $923M | $890.5M | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $16.8M | $19.7M | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $141.9B | $163.7B | $177.6B | $132.5B | $132.9B | |
| Property Plant And Equipment | $520.9M | $551M | $468.7M | $427.9M | $384.7M | |
| Long-Term Investments | $150.6B | $172.2B | $263B | $177.9B | $182.3B | |
| Goodwill | $603.8M | $655.6M | -- | $934.1M | $986M | |
| Other Intangibles | $510.8M | $651.9M | $1.1B | $438.6M | $417.8M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $278.5B | $324.4B | $284.7B | $222B | $231B | |
| Accounts Payable | $1.2B | $1.2B | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $3.5B | $3.6B | -- | $1.3B | $1.1B | |
| Long-Term Debt | $13.5B | $14.3B | $13.5B | $16.2B | $15.3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $241.7B | $276.7B | $257.9B | $199.4B | $207.6B | |
| Common Stock | $45.9M | $48M | $24.5B | $37.5M | $37.6M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $36.4B | $47.3B | $26.5B | $22.6B | $23.3B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $291.2M | $340.7M | $276.3M | $77.2M | $87.3M | |
| Total Equity | $36.7B | $47.7B | $26.8B | $22.6B | $23.3B | |
| Total Liabilities and Equity | $278.5B | $324.4B | $284.7B | $222B | $231B | |
| Cash and Short Terms | $139B | $160.6B | $177.6B | $130.5B | $130.8B | |
| Total Debt | $13.5B | $14.3B | $13.5B | $16.2B | $15.3B | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $13.9B | $8.5B | $6.5B | $7.8B | $7.3B | |
| Short Term Investments | $132.9B | $137.4B | $92B | $76.5B | $113.3B | |
| Accounts Receivable, Net | $1B | $947.3M | $803.3M | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $30.4M | $22.6M | $19.8M | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $149.6B | $148.4B | $101B | $86.2B | $122.6B | |
| Property Plant And Equipment | $529.7M | $511.7M | $445M | $410.8M | $346.2M | |
| Long-Term Investments | $159B | $153.8B | $102.5B | $133.2B | $175.1B | |
| Goodwill | $602.8M | $239.2M | $825.2M | $948.7M | $930.4M | |
| Other Intangibles | $626.4M | $1B | $820M | $432.5M | $413.8M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $295B | $297.8B | $235.8B | $222.8B | $220B | |
| Accounts Payable | $1.2B | $1B | $885.8M | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $3.5B | $3.3B | $2.8B | $908.5M | $1B | |
| Long-Term Debt | $12.5B | $13B | $13.9B | $15B | $12.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $253.2B | $256.2B | $212.9B | $200.1B | $197.2B | |
| Common Stock | $42.7M | $45.2M | $38.6M | $38M | $36.4M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $287.9M | $340.3M | $224.6M | $82.6M | $90M | |
| Total Equity | $41.8B | $41.5B | $22.9B | $22.7B | $22.7B | |
| Total Liabilities and Equity | $295B | $297.8B | $235.8B | $222.8B | $220B | |
| Cash and Short Terms | $146.9B | $145.8B | $98.6B | $84.3B | $120.6B | |
| Total Debt | $12.5B | $13B | $13.9B | $15B | $12.8B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.7B | $2.7B | $4.7B | $1.8B | $1.7B | |
| Depreciation & Amoritzation | $163.4M | $179.3M | $177.5M | $154M | $164.6M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $4.4B | $8B | -$3.1B | -$8.6B | $67.1M | |
| Capital Expenditures | $161.2M | $58.2M | $55.6M | -- | -- | |
| Cash Acquisitions | -$111.9M | -$875.9M | -$952.5M | $1.2B | -$267.4M | |
| Cash From Investing | -$8B | $628.1M | -$2.2B | $6.3B | $4.9B | |
| Dividends Paid (Ex Special Dividend) | -$460.1M | -$456.8M | -$526.5M | -$564.2M | -$463.4M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $5.3B | $5.9B | $2.8B | $11.2B | $11.5B | |
| Long-Term Debt Repaid | -$3.2B | -$6.3B | -$2.4B | -$7.2B | -$13.5B | |
| Repurchase of Common Stock | -$780.3M | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $760.1M | -$1.7B | -$876.7M | $1.9B | -$3.2B | |
| Beginning Cash (CF) | $9.9B | $7.4B | $14.7B | $7.5B | $7.2B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$2.8B | $6.9B | -$6.1B | -$361.7M | $1.7B | |
| Ending Cash (CF) | $7.2B | $14.1B | $8.5B | $7B | $8.9B | |
| Levered Free Cash Flow | $4.3B | $7.9B | -$3.1B | -$8.6B | $67.1M | |
| Period Ending | 2015-12-31 | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $162.7M | $765.8M | -$416.6M | $394.2M | |
| Depreciation & Amoritzation | -- | $13M | $56.7M | $60.5M | $42.2M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$1.8B | -$18.6M | -$1.3B | -$3.9B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -$10.9B | -$303.3M | $106.9M | -$71.9M | |
| Cash From Investing | -- | $501.9M | $694.4M | $1.6B | -$986.8M | |
| Dividends Paid (Ex Special Dividend) | -- | $2.8M | -$6.4M | -$50.6M | -$18.7M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $4B | $5.8B | $493.4M | $234.7M | |
| Long-Term Debt Repaid | -- | -$3.5B | -$6.7B | -$226M | $412.1M | |
| Repurchase of Common Stock | -- | -$556.7M | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | $487.2M | -$1B | -$49.5M | $411M | |
| Beginning Cash (CF) | -- | $10.2B | $11.4B | $9.9B | $11.7B | |
| Foreign Exchange Rate Adjustment | -- | $199.7M | -$14.2M | $107.9M | -$78.7M | |
| Additions / Reductions | -- | -$782.4M | -$354.3M | $285.5M | -$4.5B | |
| Ending Cash (CF) | -- | $9.6B | $10.6B | $10.5B | $7.2B | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | $4.5B | $707.9M | -- | |
| Depreciation & Amoritzation | -- | -- | $168.1M | $156.4M | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -$8.7B | -$1.4B | -- | |
| Capital Expenditures | -- | $24.1M | $30.9M | -- | -- | |
| Cash Acquisitions | -- | -$329M | $178.7M | $409.4M | -$239.1M | |
| Cash From Investing | -- | -- | $6.4B | $4.2B | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -$308.5M | -$485.6M | -$573M | -$179.8M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $7.1B | $12.2B | -- | |
| Long-Term Debt Repaid | -- | -- | -$4.1B | -$12.1B | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | $1.5B | -$1.7B | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -$831.4M | $1.1B | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -$8.7B | -$1.4B | -- | |
| Period Ending | 2021-01-08 | 2022-01-08 | 2023-01-08 | 2024-01-08 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get NNGRY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NNGRY
Sector
P/E ratio
9.55x
11.89x
PEG ratio
--
0.36x
P/B ratio
0.52x
1.05x
Price / LTM sales
0.99x
2.56x
Growth Metrics
NNGRY
Sector
Revenue growth
--
5.96%
Earnings growth
--
6.39%
Revenue (5-year growth)
-12.61%
5.82%
Earnings forecast
--
$0.59
Profitability
NNGRY
Sector
Profitability FY 2024
--
$172.6M
Return on invested capital
3.56%
5.23%
Return on assets
0.59%
0.97%
Return on equity
5.8%
9.37%
Earnings Date
Last Earnings Date
Aug
15
Next Earnings Date
Feb
28
Estimated Next Earnings Date
Nov
14
Balance Sheet
NNGRY
Sector
Total cash
$120.6B
$592.8M
Short term investments
$121.7B
$406.3M
Total assets
$231B
$4.4B
Long term debt
$12.8B
$261.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NAIL a Good ETF to Buy?
If you’re thinking about buying the NAIL ETF, this article…
3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Stock Ideas
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 125x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
NARI alert for Jan 7
Inari Medical [NARI] is up 22.25% over the past day.
Buy
70
PDEX alert for Jan 7
Pro-Dex [PDEX] is down 10.89% over the past day.
Buy
52
ALCO alert for Jan 7
Alico [ALCO] is down 3.89% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
